Edwards Lifesciences Corp (NYSE:EW)
| 82.01 Delayed Data As of May 26 |  +0.36 / +0.44%Today’s Change | 67.13 Today|||52-Week Range 107.92 | +9.92% Year-to-Date |
Latest EW News | Press Releases
| Edwards Lifesciences (EW) Down 5.9% Since Last Earnings Report: Can It Rebound? May 26 / Zacks.com - Paid Partner Content | Edwards Lifesciences' (EW) TAVR Study Outcome Favorable May 18 / Zacks.com - Paid Partner Content |
| Top Stock Reports for Home Depot, Linde & Walt Disney May 25 / Zacks.com - Paid Partner Content | ITGR vs. EW: Which Stock Is the Better Value Option? May 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 81.65 |
| Today’s open | 81.40 |
| Day’s range | 81.33 - 82.09 |
| Volume | 2,308,782 |
| Average volume (3 months) | 3,176,459 |
| Market cap | $49.7B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +1.95% |
| Earnings growth (this year) | +2.84% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +2.86% |
| P/E ratio | 34.0 |
| Price/Sales | 8.65 |
| Price/Book | 8.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STESTERIS plc | -0.76 | -0.38% |
| SNNSmith & Nephew PLC | +0.16 | +0.53% |
| ---- | ||
| INSPInspire Medical Syst... | -2.08 | -0.70% |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | July 27, 2023 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $5.4B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 28.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
